Do Physiotherapy Techniques Improve Posture During Admission for a Chest Infection in Adults With Cystic Fibrosis?
Do Physiotherapy Joint and Muscle Movement (Musculoskeletal) Techniques Improve Posture, Pain, Sputum Clearance, Lung Function or Quality of Life During Admission for a Respiratory Exacerbation in Adults With Cystic Fibrosis?
2 other identifiers
interventional
50
1 country
1
Brief Summary
Hypothesis: The addition of a series of musculoskeletal techniques to normal optimal care for the treatment of a respiratory exacerbation in inpatient adults with cystic fibrosis, will lead to further improvements in pain, posture, sputum clearance, lung function and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 10, 2008
CompletedFirst Posted
Study publicly available on registry
December 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedJune 8, 2015
December 1, 2008
1.2 years
December 10, 2008
June 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Thoracic index as measured by the flexicurve (Boyle, Bradley et al. 2008).
Day 0 of admission, Days 5,10 & prior to discharge
Secondary Outcomes (6)
Lung function: forced expiratory volume in one second (FEV1), forced vital capacity (FVC)
Days 0,5,10 & pre discharge
Pain assessment using a 10-centimetre visual analogue scale
Days 0,5,10 & pre discharge
Sputum weight
Days 0,5,10
Ease of sputum clearance using a 10-centimetre visual analogue scale
Days 0,5,10 & pre discharge
Quality of life - CF-38 questionnaire (Ethics reference number: 98-167)
Days 0 & pre discharge
- +1 more secondary outcomes
Study Arms (2)
Control Arm1
OTHERNormal optimal medical and physiotherapy treatment
Treatment Arm 2
EXPERIMENTALPhysiotherapy musculoskeletal interventions in addition to normal optimal medical and physiotherapy care
Interventions
Other: Physiotherapy Musculoskeletal Treatment Specific, gentle oscillatory mobilisations to the rib cage and thoracic spine of the subjects to improve joint alignment and mobility, and to reduce pain. Treatment of specific muscle dysfunction or tight muscle groups to further optimise muscle length and biomechanical relationships in the area , leading to improved efficiency of recruitment and improved power output. Postural education and awareness discussions to improve the subject's own joint alignment and ability in a functional manner. A short programme to reinforce the progress during the treatment sessions may be given.
Eligibility Criteria
You may qualify if:
- Diagnosis of cystic fibrosis (genotype or sweat sodium \>70 millimoles per litre or sweat chloride of \>60 millimoles per litre)
- years of age or over
- Inpatient admission for respiratory exacerbation as defined by the Cystic Fibrosis Trust (Cystic Fibrosis Trust Antibiotic Group 2002)
- Inpatients able to stand for the measurement period without cardiovascular or respiratory compromise.
You may not qualify if:
- Current severe haemoptysis
- Low bone density (Z score \< -3)(World Health Organisation Study Group 1994)
- Rib fractures
- Pregnancy
- Inability to give consent for treatment/ measurement
- Planned initiation or continuation of treatment in the home environment
- Current participation in another study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Brompton Hospital
London, London, SW3 6NP, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Professor ME Hodson
Imperial College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 10, 2008
First Posted
December 11, 2008
Study Start
June 1, 2008
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
June 8, 2015
Record last verified: 2008-12